TSPO and Parkinson disease: Dopaminergic deficits in PD are accompanied by neuroinflammation in the form of astrogliosis and microglial activation and proliferation that leads to expression of various proteins, including major histocompatibility complex class II (MHCII) and the 18 kDA translocator protein (TSPO) [13,14].